January 1, 2016. Dr. Sen Gupta's group at CWRU has received a Phase I Ohio Third Frontier Technology Validation and Startup Fund award ($50,000) to evaluate the commercialization potential of the SynthoPlate technology.
December 1, 2015. Drs. Christa Pawlowski and Anirban Sen Gupta participated in the Fall 2015 cohort of the Innovation-Corps (I-Corps) program at Cleveland Clinic.
July 1, 2015. Dr. Sen Gupta's group at CWRU has been awarded two grants to evaluate the scaled-up manufacturing and clinical promise of the SynthoPlate technology in large animal models of traumatic hemorrhage.
March 1, 2014. Dr. Sen Gupta's group at CWRU receives 5 year, $1.9 million NIH R01 grant to develop the SynthoPlate technology.